PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Active, not recruiting · NCT02571725 · Registry updated 2025-05-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer | Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-05-23 | NCT02571725 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| New Mexico Cancer Research Alliance | 7 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moffitt Cancer Center | Tampa | United States | 523 |
| Southwest Gynecologic Oncology Associates | Albuquerque | United States | 1 |
| The Ohio State University | Columbus | United States | 191 |
| University of New Mexico Comprehensive Cancer Center | Albuquerque | United States | 16 |
| University of Virginia Cancer Center | Charlottesville | United States | 11 |